Date | Price Target | Rating | Analyst |
---|---|---|---|
9/8/2022 | $10.00 | Buy | Citigroup |
4/11/2022 | $19.00 | Outperform | Cowen |
Allego (NYSE:ALLG), a leading pan-European public electric vehicle fast and ultra-fast charging network, today announced that it has completed the voluntary delisting of its ordinary shares (the "Shares") from the New York Stock Exchange ("NYSE") following the conclusion of the previously announced tender offer by Madeleine Charging B.V., Allego's majority shareholder. Allego filed Form 25 with the U.S. Securities and Exchange Commission ("SEC") on August 12, 2024, relating to the delisting of the Shares in accordance with Rule 12d2-2 declared under the Securities Exchange Act of 1934, as amended. Today, August 22, 2024, is the last trading day of the Shares on the NYSE. As Allego trans
Allego (NYSE:ALLG), a leading pan-European electric vehicle network, announces the grant of a €20 million loan from the European Bank for Reconstruction and Development (EBRD) as part of the CROSS-E project co-funded by the European Union. This financial support will support Allego's strong development of EV-charging infrastructure inside Poland as part of the company's ongoing Eastern European expansion project. Electric vehicle adoption in Poland, which ranks among the lowest in Europe in terms of EV charging penetration, can only be fostered through a robust and fully functional EV charging infrastructure. This initiative promotes the broad availability of efficient and dependable elec
Allego N.V. ("Allego" or the "Company") (NYSE:ALLG), a leading provider of electric vehicle charging solutions, today announced that it has commenced the process to voluntarily delist its ordinary shares (the "Shares") from the New York Stock Exchange ("NYSE") following the completion of the previously announced tender offer by Madeleine Charging B.V., Allego's majority shareholder. The Company intends to file a Form 25 with the U.S. Securities and Exchange Commission ("SEC") on August 12, 2024, relating to the delisting of the Shares, in accordance with Rule 12d2-2 promulgated under the Securities Exchange Act of 1934, as amended, which delisting is expected to take effect ten days there
25 - Allego N.V. (0001874474) (Filer)
6-K - Allego N.V. (0001874474) (Filer)
SC 14D9/A - Allego N.V. (0001874474) (Subject)
Allego N.V. ("Allego" or the "Company") (NYSE:ALLG), a leading pan-European public electric vehicle fast and ultra-fast charging network, today announced it will postpone its fourth quarter and full year 2023 financial results conference call and confirms that it will provide that information in connection with the filing of its Form 20-F on or prior to the April 30, 2024 deadline. Allego had previously announced it would report its financial results before the market opens on April 2, 2024, with a conference call taking place at 8:30 a.m. Eastern Time. About Allego Allego is a leading provider of electric vehicle charging solutions, dedicated to accelerating the transition to electri
Allego N.V. ("Allego" or the "Company") (NYSE:ALLG), a leading pan-European public electric vehicle fast and ultra-fast charging network, today announced it will release the Company's fourth quarter and full year 2023 results on Tuesday, April 2, 2024, followed by a conference call at 8:30 AM ET. Participants may access the call at 1-877-407-9716, international callers may use 1-201-493-6779 and request to join the Allego earnings call. A live webcast will also be available at https://ir.allego.eu/events-publications. A telephonic replay of the call will be available shortly after the conclusion of the call and until Tuesday, April 16, 2024. Participants may access the replay at 1-844-5
Third quarter 2023 revenue increased 28.2% to €28.6 million, compared to €22.3 million in the prior year period. Third quarter 2023 charging revenue increased 53.0% to €22.0 million, compared to €14.4 million for the three months ended September 30, 2022. Gross profit increased to €5.4 million compared to €(4.6) million in the prior-year-period; gross margin during the quarter was 18.9%. Third quarter 2023 net loss was €(43.1) million, compared to €(22.1) million in the prior-year period; Operational EBITDA was €2.6 million reflecting higher charging revenue and improved charging gross margin compared to the prior-year period loss of €(3.1) million. Allego recently signed two p
U.S. stocks traded mixed this morning, with the Nasdaq Composite edging lower on Tuesday. Following the market opening Tuesday, the Dow traded up 0.25% to 38,875.50 while the NASDAQ fell 0.12% to 17,836.13. The S&P 500 also rose, gaining, 0.15% to 5,481.48. Check This Out: Wall Street’s Most Accurate Analysts Weigh In On 3 Real Estate Stocks With Over 8% Dividend Yields Leading and Lagging SectorsEnergy shares jumped by 1.6% on Tuesday. In trading on Tuesday, consumer discretionary shares fell by 0.4%. Top Headline U.S. retail sales rose 0.1% month-over-month in May compared to a revised 0.2% declined in April and missing market expectations of 0.2% gain. Equities Tradi
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging over 200 points on Monday. The Dow traded up 0.57% to 38,807.47 while the NASDAQ rose 1.22% to 17,904.35. The S&P 500 also rose, gaining, 0.95% to 5,483.45. Check This Out: Top 4 Risk Off Stocks That May Rocket Higher In Q2 Leading and Lagging SectorsConsumer staples shares jumped by 1.5% on Monday. In trading on Monday, real estate shares fell by 0.6%. Top Headline The NY Empire State Manufacturing Index rose to -6 in June versus a reading of -15.6 in May and coming in better than market expectations of -12.50. Equities Trading UP Mustang Bio, Inc. (NASDAQ:M
Shares of Ovid Therapeutics Inc (NASDAQ:OVID) dipped 65.7% to $1.1285 after Takeda’s Skyline study in Dravet syndrome missed its primary endpoint. Takeda Pharmaceutical Co Ltd (NYSE:TAK) announced topline data from its SKYLINE and SKYWAY Phase 3 studies of Soticlestat (TAK-935) for the treatment of Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS). AMMO shares dipped 19.1% to $2.0306 on Friday. Here are some other stocks moving in today’s mid-day session. Gainers Interactive Strength Inc. (NASDAQ:TRNR) shares climbed 148% to $7.07 after dipping 19% on Friday. Mustang Bio, Inc. (NASDAQ:MBIO) shares jumped 145% to $0.32 after the company announced safety and efficacy da
SC 13D - Allego N.V. (0001874474) (Subject)
SC 13G/A - Allego N.V. (0001874474) (Subject)
SC 13G - Allego N.V. (0001874474) (Subject)
Seasoned financial executive to bring decades of experience in the industrial sectors to a leading provider of electric vehicle charging solutions Allego N.V. ("Allego" or the "Company") (NYSE:ALLG), a leading provider of electric vehicle charging solutions, is pleased to announce the appointment of Steven Salo as the Company's new Chief Financial Officer (CFO), effective July 1st, 2024. Steven brings extensive experience in financial leadership, strategic planning, and corporate development to Allego. Born in the UK, Steven went on to study in Australia, graduating from Deakin University, Melbourne, with a Bachelor of Commerce and from Finsia with a Masters of Applied Finance and Inves
Citigroup initiated coverage of Allego Holding B.V. with a rating of Buy and set a new price target of $10.00
Cowen initiated coverage of Allego Holding B.V. with a rating of Outperform and set a new price target of $19.00